Blog

Product strategy, conversion systems, and telehealth operations for teams building modern care journeys.

FeaturedLongevity

The Longevity Stack: Combining NAD+, Peptides, GLP-1, and Rapamycin in One DTC Program

Longevity patients rarely want a single compound. They want a stack. Combining NAD+, peptides, GLP-1, and rapamycin in one DTC program is a real opportunity, but only if intake, provider scope, sequencing, billing, and compliance are built for a multi-compound model instead of bolted together from separate funnels.

Read featured article
AllAIGLP-1GrowthLongevityOperationsPatient ExperienceProduct UpdatesTelehealth
Longevity

NAD+ Delivery Formats Compared: IV vs. Injection vs. Nasal Spray vs. Oral Precursors

NAD+ is the same molecule no matter how a patient takes it, but the delivery format changes everything about evidence, cost, adherence, compliance, and patient experience. This is how DTC telehealth teams should compare IV, subcutaneous injection, nasal spray, and oral precursors before building a NAD+ program.

Read post